Health ❯Healthcare ❯Medical Treatments

Neurology

Alzheimer's Disease Parkinson's Disease

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

FDA Approves Vyalev for Advanced Parkinson's Disease Treatment

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety